Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Sanofi
SNY
$104B
| $11.1M | ﹤0.01% |
200,615
+48,670
| +32% | +$2.63M |
|
1902
Innoviva
INVA
$1.48B
| $11.1M | ﹤0.01% |
609,805
-17,857
| -3% | -$320K |
|
1903
A10 Networks
ATEN
$1.93B
| $11M | ﹤0.01% |
675,676
+7,246
| +1% | +$139K |
|
1904
Cohu
COHU
$2.5B
| $11M | ﹤0.01% |
750,515
+73,145
| +11% | +$1.52M |
|
|
EFC
1905
Ellington Financial
EFC
$1.71B
| $11M | ﹤0.01% |
831,884
+10,860
| +1% | +$140K |
|
1906
Dime Commercial Bancshares
DCOM
$1.78B
| $11M | ﹤0.01% |
395,529
+44,696
| +13% | +$1.35M |
|
|
EVRI
1907
DELISTED
Everi Holdings
EVRI
| $11M | ﹤0.01% |
804,811
+1,043
| +0.1% | +$14.2K |
|
1908
John B. Sanfilippo & Son
JBSS
$972M
| $11M | ﹤0.01% |
154,566
+11,955
| +8% | +$914K |
|
1909
Tandem Diabetes Care
TNDM
$1.53B
| $10.9M | ﹤0.01% |
570,150
-32,171
| -5% | -$941K |
|
1910
DXP Enterprises
DXPE
$2.98B
| $10.9M | ﹤0.01% |
132,055
-18,698
| -12% | -$1.73M |
|
|
MRC
1911
DELISTED
MRC Global
MRC
| $10.8M | ﹤0.01% |
944,831
-91,231
| -9% | -$1.18M |
|
|
PYCR
1912
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $10.8M | ﹤0.01% |
483,031
-12,228
| -2% | -$271K |
|
1913
Middlesex Water
MSEX
$1.1B
| $10.8M | ﹤0.01% |
169,014
-3,458
| -2% | -$188K |
|
1914
Harmonic Inc
HLIT
$1.28B
| $10.8M | ﹤0.01% |
1,128,795
+71,225
| +7% | +$785K |
|
1915
Asana
ASAN
$2.13B
| $10.8M | ﹤0.01% |
742,272
+47,480
| +7% | +$901K |
|
1916
National Beverage
FIZZ
$3.01B
| $10.8M | ﹤0.01% |
260,290
-11,368
| -4% | -$468K |
|
1917
Madison Square Garden
MSGE
$3.62B
| $10.8M | ﹤0.01% |
329,784
-10,193
| -3% | -$355K |
|
|
DCH
1918
Dauch Corp
DCH
$1.51B
| $10.8M | ﹤0.01% |
2,649,397
+444,134
| +20% | +$2.28M |
|
1919
CG Oncology
CGON
$6.62B
| $10.8M | ﹤0.01% |
439,278
+11,518
| +3% | +$324K |
|
1920
OceanFirst Financial
OCFC
$1.91B
| $10.8M | ﹤0.01% |
632,186
-101,799
| -14% | -$1.81M |
|
1921
Immunovant
IMVT
$8.25B
| $10.7M | ﹤0.01% |
626,612
+62,170
| +11% | +$1.3M |
|
1922
NeoGenomics
NEO
$2.13B
| $10.7M | ﹤0.01% |
1,126,896
-34,456
| -3% | -$430K |
|
1923
Veeco
VECO
$3.23B
| $10.7M | ﹤0.01% |
530,956
+22,186
| +4% | +$531K |
|
|
ARR
1924
Armour Residential REIT
ARR
$2.36B
| $10.6M | ﹤0.01% |
621,548
+121,806
| +24% | +$2.27M |
|
1925
SunCoke Energy
SXC
$797M
| $10.6M | ﹤0.01% |
1,154,699
+114,609
| +11% | +$1.1M |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.